Scientists at the Center for Biomedical Research of the SumDU Medical Institute are successfully researching fundamental properties of MXenes to use them in medicine and other fields.

The Center is currently implementing the EURIZON-BRC-SUMY project “Biomedical Properties and Biosafety of MXenes, New Graphene-like 2D Nanomaterials”.

The EURIZON H2020 Research Fellowship Program is funded by the European Union. It aims to support the ability of Ukrainian research teams to continue their research during the armed aggression of Russia in cooperation with partners from European research institutions.

Research under the EURIZON-BRC-SUMY project (01.05.2024 – 30.04. 2025) is led by Serhii KYRYLENKO. It is carried out by Inna CHORNA, Artem SHMATKOV, Yulia VARAVA, Viacheslav KUKURIKA, Anton ROSHCHUPKIN, Milena YALYZHKO, Andrii LIUTYI.

The project development and implementation were possible through close cooperation and support from Materials Research Center/Carbon Ukraine (a world leader in development and production of MXenes in Kyiv).

“The project has already brought significant results. We submitted papers for two international conferences – YUCOMAT 2024 and NAP 2024. We prepared an article for publication in a prestigious journal. We have shown that MXenes can induce a DNA comet effect regardless of the MXenes nature and cell type. The results are important to understand interaction of MXenes with the body, which is absolutely necessary when using new materials to treat diseases. Thus, MXenes have a high potential for cancer treatment, tissue engineering, etc. We hope that our project will make a significant contribution to consideration of these processes,” – noted Serhii KYRYLENKO.

The project coordination is carried out by Lucia DELOGU (University of Padova in Italy). Also, advisory support is provided by Yuri HOHOTSI (Drexel University in the USA) and leading scientists (University of Latvia, Riga).

The EURIZON-BRC-SUMY project is implemented in close synergy with the projects HORIZON-MSCA-2021-SE #101086184 MX-MAP; HORIZON-MSCA-2022-SE #101131147 ESCULAPE of the European Commission and the EOARD grant of the Air Force Office of Scientific Research of the United States Government.